OTCMKTS:TCHBF Tecan Group (TCHBF) Stock Price, News & Analysis $208.03 0.00 (0.00%) As of 01/7/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest About Tecan Group Stock (OTCMKTS:TCHBF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tecan Group alerts:Sign Up Key Stats Today's Range$208.03▼$208.0350-Day Range$208.03▼$277.0052-Week Range$208.03▼$340.27VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E Ratio48.72Dividend Yield0.72%Price TargetN/AConsensus RatingN/A Company OverviewTecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.Read More… Tecan Group Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks13th Percentile Overall ScoreTCHBF MarketRank™: Tecan Group scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Tecan Group. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Tecan Group is 48.72, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.56.Price to Earnings Ratio vs. SectorThe P/E ratio of Tecan Group is 48.72, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 87.10. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverTecan Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tecan Group has recently increased by 12.06%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend LeadershipTecan Group is a leading dividend payer. It pays a dividend yield of 4.42%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthTecan Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Tecan Group is 35.13%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Tecan Group's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverTecan Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tecan Group has recently increased by 12.06%, indicating that investor sentiment is decreasing significantly. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Tecan Group this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Tecan Group insiders have not sold or bought any company stock.Percentage Held by Institutions46.80% of the stock of Tecan Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Tecan Group's insider trading history. Receive TCHBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tecan Group and its competitors with MarketBeat's FREE daily newsletter. Email Address TCHBF Stock News HeadlinesTecan meets revised sales outlook for fiscal year 2024January 8 at 5:17 PM | finance.yahoo.comTecan to present at upcoming Investor ConferencesJanuary 6 at 5:33 PM | finance.yahoo.comWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nice stream of income along the way.January 8, 2025 | Behind the Markets (Ad)Tecan price target lowered to CHF 264 from CHF 328 at BerenbergNovember 19, 2024 | markets.businessinsider.comTecan downgraded to Neutral from Buy at UBSNovember 3, 2024 | markets.businessinsider.comTecan Group Share Chat (0QLN)November 1, 2024 | lse.co.ukAnalysts Offer Insights on Healthcare Companies: Tecan Group AG (OtherTCHBF) and Argenx Se (ARGX)November 1, 2024 | markets.businessinsider.comTecan price target lowered to CHF 259 from CHF 300 at Morgan StanleyOctober 25, 2024 | markets.businessinsider.comSee More Headlines TCHBF Stock Analysis - Frequently Asked Questions How have TCHBF shares performed this year? Tecan Group's stock was trading at $208.03 at the beginning of the year. Since then, TCHBF stock has increased by 0.0% and is now trading at $208.03. View the best growth stocks for 2025 here. How do I buy shares of Tecan Group? Shares of TCHBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryPersonal Services Current SymbolOTCMKTS:TCHBF CUSIPN/A CIKN/A Webwww.tecan.com Phone(144) 922-8888FaxN/AEmployees3,315Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio48.72 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report This page (OTCMKTS:TCHBF) was last updated on 1/8/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBuried SECRET from Apollo moon landing finally revealedIf you think history books taught you everything about the Apollo moon landing... you need to see this shockin...NewMarket Health Publishing, LLC. | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tecan Group AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Tecan Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.